Lawsuits Filed in UCLA CRE Exposure Event
Lawsuits have been filed against medical device manufacturer Olympus on behalf of two patients who were infected with a drug-resistant “superbug” while undergoing an endoscopic procedure at UCLA Ronald Reagan Medical Center.
Details of the Olympus Lawsuits
According MassDevice, the lawsuits were filed on behalf of an 18-year-old high school student who remains hospitalized, and another patient, identified as Antonia Cerda, who died of after being infected.
Both patients underwent a procedure which made use of Olympus’ reusable duodenoscope – the lawsuits allege the procedure exposed the patients to Carbapenem-Resistant Enterorbacteriaceae (CRE). The lawsuits further allege Olympus’ duodenoscope is unsafe due to the product’s sterilization protocols not being updated following a recent redesign.
The suits are seeking unspecified damages for Olympus’ alleged fraud and negligence. The plaintiffs and UCLA both maintain that medical staff followed Olympus’ current cleaning protocols.
About the CRE Exposure Event
- UCLA has notified and sent test kits to 180 patients who were potentially exposed to CRE during endoscopic events.
- In all, seven infections have been confirmed and two patients have died.
- CRE infection carries a mortality rate between 40% and 50%.
- In a similar event that occurred in Seattle in 2012, 32 patients were infected and 11 died.